[Modification of labyrinthine blood circulation].
D000208:Acute Disease; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003911:Dextrans / Q000494:pharmacology / Q000627:therapeutic use*; D007758:Ear, Inner / Q000098:blood supply*; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology; D007601:Jugular Veins; D009539:Nicotinic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D012039:Regional Blood Flow / Q000187:drug effects; D012867:Skin / Q000098:blood supply; D013806:Theophylline / Q000494:pharmacology / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000494:pharmacology
D003911:Dextrans; D007546:Isoquinolines; D009539:Nicotinic Acids; D014665:Vasodilator Agents; D013806:Theophylline
Untersuchungen zur Beeinflussbarkeit der Innenohdrurchblutung.